Testing effectiveness (Phase 2)Active Not RecruitingNCT05321420What this trial is testingLYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)Who this might be right forIdiopathic Pulmonary Fibrosis PureTech 240
Large-scale testing (Phase 3)Study completedNCT00095147What this trial is testingAbatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Bristol-Myers Squibb 431
Large-scale testing (Phase 3)Study completedNCT05455684What this trial is testingAticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant TherapyWho this might be right forDepressive Disorder, MajorAnhedonia Janssen Research & Development, LLC 513
Testing effectiveness (Phase 2)Study completedNCT01684163What this trial is testingEfficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to AntidepressantsWho this might be right forMajor Depressive Disorder Naurex, Inc, an affiliate of Allergan plc 369
Testing effectiveness (Phase 2)Study completedNCT03130933What this trial is testingComplications After Lower Third Molar SurgeryWho this might be right forPostoperative ComplicationsThird Molar University of Zagreb 400
Testing effectiveness (Phase 2)Study completedNCT00580125What this trial is testingDose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of SchizophreniaWho this might be right forSchizophrenia Pfizer 164
Testing effectiveness (Phase 2)Active Not RecruitingNCT04862221What this trial is testingTReatment for ImmUne Mediated PathopHysiologyWho this might be right forAcute Liver FailureFulminant Hepatic FailureHepatic Encephalopathy+2 more National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 44
Testing effectiveness (Phase 2)Study completedNCT00316238What this trial is testingA Study Using Rapid Acting Intramuscular Olanzapine in Agitated Patients With SchizophreniaWho this might be right forSchizophrenia Eli Lilly and Company 160
Not applicableStudy completedNCT06931158What this trial is testingHOnest Placebos With Explanations: Evaluating Open-Label Placebos for Chronic PainWho this might be right forChronic Low-back PainChronic Pain Rhode Island Hospital 327
Large-scale testing (Phase 3)Ended earlyNCT01015443What this trial is testingCancer Vaccine Study for Stage III, Unresectable, Non-small Cell Lung Cancer (NSCLC) in the Asian PopulationWho this might be right forNon-Small Cell Lung Cancer Merck KGaA, Darmstadt, Germany 285
Testing effectiveness (Phase 2)Ended earlyNCT04458298What this trial is testingEvaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) PatientsWho this might be right forCOVID-19 Ashvattha Therapeutics, Inc. 28
Testing effectiveness (Phase 2)Ended earlyNCT01999192What this trial is testingStudy to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Biotest 321
Post-approval studies (Phase 4)Study completedNCT01852500What this trial is testingAre Newborns Conscious of the Placebo Effect? Result From an RCT in OsteopathyWho this might be right forPrematurity European Institute for Evidence Based Osteopathic Medicine 250
Large-scale testing (Phase 3)Study completedNCT06715319What this trial is testingObeticholic Acid Versus Placebo, in Combination with Ursodeoxycholic Acid in Patients with Primary Biliary CirrhosisWho this might be right forPBC Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 100
Not applicableStudy completedNCT04951336What this trial is testingRCT of Mushroom Based Natural Product to Enhance Immune Response to COVID-19 VaccinationWho this might be right forCOVID-19 Vaccination University of California, San Diego 90
Early research (Phase 1)Study completedNCT01523067What this trial is testingSafety, Tolerability, Pharmacokinetics and Pharmacodynamics Response of Vasomera (PB1046) Injection Following a Single Subcutaneous Dose in Subjects With Stage 1 or 2 Essential HypertensionWho this might be right forEssential Hypertension PhaseBio Pharmaceuticals Inc. 68
Early research (Phase 1)Study completedNCT02028403What this trial is testingSafety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral TherapyWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06867042What this trial is testingTacrolimus Lipid Suspension for Enema in Adult Subjects with Mild to Moderately Active Left-sided/Distal Ulcerative Colitis Who Had an Inadequate Response to the TreatmentWho this might be right forUlcerative Colitis (UC)Ulcerative Colitis, Active Moderate Jina Pharmaceuticals Inc. 150
Not applicableEnded earlyNCT04669379What this trial is testingIs an Online-tool Capable of Improving Patients' Outcomes After Surgery?Who this might be right forPatients Undergoing Surgery Philipps University Marburg 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07665996What this trial is testingA Phase Ib/IIa Study Assessing the Rapid Onset Characteristics of TLL-018 for Moderate-to-Severe CSU With Inadequate Response to Second-Generation H1 AntihistaminesWho this might be right forChronic Spontaneous Urticaria (CSU) Hangzhou Highlightll Pharmaceutical Co., Ltd 36